Mats Brannstrom

Title: Innovations in Ovarian Cancer Diagnosis by Mats Brannstrom

Introduction

Mats Brannstrom is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of medical diagnostics, particularly in the area of ovarian cancer. His work focuses on developing innovative methods that enhance the accuracy of cancer diagnosis.

Latest Patents

Mats Brannstrom holds a patent for "Methods for diagnosing ovarian cancer." This invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. The biomarkers developed in this patent are instrumental in classifying a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease, or other malignant conditions. These biomarkers can be detected using techniques such as SELDI mass spectrometry, immunoassay, or other means.

Career Highlights

Mats Brannstrom is associated with Vermillion Corporation, where he continues to work on advancing diagnostic technologies. His expertise in the field has positioned him as a key figure in the development of innovative solutions for cancer diagnosis.

Collaborations

Mats collaborates with notable colleagues, including Eric Thomas Fung and Tai-Tung Yip. Their combined efforts contribute to the advancement of research and development in the medical diagnostics sector.

Conclusion

Mats Brannstrom's work in ovarian cancer diagnosis exemplifies the impact of innovation in healthcare. His patented methods and collaboration with other experts highlight the importance of research in improving patient outcomes.